Journal of Shandong University (Health Sciences) ›› 2019, Vol. 57 ›› Issue (12): 62-67.doi: 10.6040/j.issn.1671-7554.0.2019.983

Previous Articles    

Clinical features and prognosis of adult secondary hemophagocytic syndrome: an analysis of 32 cases

LI Fan1, SHAO Jianhua2, ZHAO Hongyu2, DOU Chunhui2, LÜ Yahui1, LI Daqi2   

  1. 1. School of Clinical Medicine, Weifang Medical College, Weifang 261053, Shandong, China;
    2. Department of Hematology, Jinan Central Hospital Affiliated to Shandong University, Jinan 250013, Shandong, China
  • Published:2022-09-27

PDF (PC)

159

Abstract: Objective To investigate the clinical features and prognostic factors of adult secondary hemophagocytic lymphohistiocytosis(HLH). Methods Clinical data of 32 cases of adult secondary HLH were collected, clinical features, etiology and recurrence were reviewed, and prognostic factors were analyzed with univariate and Cox multivariate analyses. Results Of the 32 patients, 17(53%)were male and 15(47%)were female, median age 57(19-88)years. Fever and elevated serum ferritin were observed in 32 cases, hepatosplenomegaly in 26 cases, and cytopenia in 25 cases. Etiology analyses showed that 14 cases(43.75%)were caused by malignant tumors, 10(31.25%)by infections, and 8(25%)by other factors. Ultimately 24(75%)deaths occurred. The median survival was 27 days and recurrence rate was 11.1%. One-way analysis of variance showed that age, rash, hemoglobin, triglyceride, clotting time and activated partial prothrombin time were related to death(P<0.05). Cox multivariate analysis indicated that age and triglyceride level were independent risk factors for prognosis. Conclusion Secondary HLH in adults has diverse etiology and clinical features. Advanced age and high triglyceride level are independent prognostic factors associated with death.

Key words: Clinical features, Hemophagocytic lymphohistiocytosis, Prognostic factors, Recurrence

CLC Number: 

  • R551.3
[1] Risdall RJ, McKenna RW, Nesbit ME, et al. Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis[J]. Cancer, 1979, 44(3): 993-1002.
[2] Henter JI, Horne A, Aricó M, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis[J]. Pediatr Blood Cancer, 2007, 48(2): 124-131.
[3] Marsh RA, Allen CE, McClain KL, et al. Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab[J]. Pediatr Blood Cancer, 2013, 60(1): 101-109.
[4] Wang Y, Huang W, Hu L, et al. Multicenter study of combination DEP regimen as a salvage therapy for adult refractory hemophagocytic lymphohistiocytosis[J]. Blood, 2015, 126(19): 2186-2192.
[5] Farquhar JW, Claireaux AE. Familial haemophagocytic reticulosis[J]. Arch Dis Child, 1952, 27(136): 519-525.
[6] Janka G. Hemophagocytic lymphohistiocytosis: when the immune system runs amok[J]. Klin Padiatr, 2009, 221(5): 278-285.
[7] Zhang L, Zhou J, Sokol L. Hereditary and acquired hemophagocytic lymphohistiocytosis[J]. Cancer control, 2014, 21(4): 301-312.
[8] Xu XJ, Wang HS, Ju XL, et al. Clinical presentation and outcome of pediatric patients with hemophagocytic lymphohistiocytosis in China: A retrospective multicenter study[J]. Pediatr Blood Cancer, 2017, 64(4). doi: 10.1002/pbc.26264.
[9] Zhang Z, Wang J, Ji B, et al. Clinical presentation of hemophagocytic lymphohistiocytosis in adults is less typical than in children[J]. Clinics(Sao Paulo), 2016, 71(4): 205-209.
[10] Lim SH, Park S, Jang JH, et al. Clinical significance of bone marrow hemophagocytosis in adult patients with malignancy and non-malignancy-induced hemophagocytic lymphohistiocytosis[J]. Ann ematol, 2016, 95(2): 325-335.
[11] Fukaya S, Yasuda S, Hashimoto T, et al. Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 cases[J]. Rheumatology(Oxford), 2008, 47(11): 1686-1691.
[12] Fei Li, Yijun Yang, Fengyan Jin, et al. Clinical characteristics and prognostic factors of adult hemophagocytic syndrome patients: a retrospective study of increasing awareness of a disease from a single-center in China[J]. Orphanet J Rare Dis, 2015, 10: 20. doi: 10.1186/s13023-015-0224-y.
[13] Arca M, Fardet L, Galicier L, et al. Prognostic factors of early death in a cohort of 162 adult haemophagocytic syndrome: impact of triggering disease and early treatment with etoposide[J]. Br J Haematol, 2015, 168(1): 63-68.
[14] Aulagnon F, Lapidus N, Canet E, et al. Acute kidney injury in adults with hemophagocytic lymphohistiocytosis[J]. Am J Kidney Dis, 2015, 65(6): 851-859.
[15] Parikh SA, Kapoor P, Letendre L, et al. Prognostic factors and outcomes of adults with hemophagocytic lymphohistiocytosis[J]. Mayo Clin Proc, 2014, 89(4): 484-492.
[16] Takahashi N, Chubachi A, Kume M, et al. A clinical analysis of 52 adult patients with hemophagocytic syndrome: the prognostic significance of the underlying diseases[J]. Int J Hematol, 2001, 74(2): 209-213.
[17] Rivière S, Galicier L, Coppo P, et al. Reactive hemophagocytic syndrome in adults: a retrospective analysis of 162 patients[J]. Am J Med, 2014, 127(11): 1118-1125.
[18] 林珺芳, 曾志勇, 杨阿碰, 等. 合并噬血细胞综合征对非霍奇金淋巴瘤患者的临床预后影响及影响因素分析[J]. 中国实验血液学杂志, 2017, 25(4): 1042-1046. LIN Junfang, ZENG Zhiyong, YANG Apeng, et al. Effect of Complicated Hemophagocytic Syndrome on Clinical Prognosis of Patients with Non-Hodgkins Lymphoma and Analysis of Its Affecting Factors[J]. Journal of Experimental Hematology, 2017, 25(4): 1042-1046.
[19] Kaito K, Kobayashi M, Katayama T, et al. Prognostic factors of hemophagocytic syndrome in adults: analysis of 34 cases[J]. Eur J Haematol, 1997, 59(4): 247-253.
[20] Li J, Wang Q, Zheng W, et al. Hemophagocytic lymphohistiocytosis: clinical analysis of 103 adult patients[J]. Medicine(Baltimore), 2014, 93(2): 100-105.
[21] Otrock ZK, Eby CS. Clinical characteristics, prognostic factors, and outcomes of adult patients with hemophagocytic lymphohistiocytosis[J]. Am J Hematol, 2015, 90(3): 220-224.
[22] Buyse S, Teixeira L, Galicier L, et al. Critical care management of patients with hemophagocytic lymphohistiocytosis[J]. Intensive Care Med, 2010, 36(10): 1695-1702.
[23] Tseng YT, Sheng WH, Lin BH, et al. Causes, clinical symptoms, and outcomes of infectious、diseases associated with hemophagocytic lymphohistiocytosis in Taiwanese adults[J]. J Microbiol Immunol Infect, 2011, 44(3): 191-197.
[24] Okamoto M, Yamaguchi H, Isobe Y, et al. Analysis of triglyceride value in the diagnosis and treatment response of secondary hemophagocytic syndrome[J]. Intern Med, 2009, 48(10): 775-781.
[25] Tengku-Muhammad TS, Hughes TR, Cryer A, et al. Differential regulation of lipoprotein lipase in the macrophage J774.2 cell line by cytokines[J]. Cytokine, 1996, 8(7): 525-533.
[26] Xue H, Chen C, Li W, et al. Analysis of prognostic risk factors in children with Epstein-Barr virus-associated hemophagocytic syndrome[J]. Minerva Pediatr, 2015, 67(3): 251-261.
[27] Yanagisawa R, Matsuda K, Ohga S, et al. Correction to: Factors predicting the recurrence of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children after treatment using the HLH-2004 protocol[J]. Int J Hematol, 2019, 109(5): 629.
[1] GAO Zhongxia, ZHANG Ming, FAN Mingde, TAN Chenyang, WANG Mengdi, WANG Chao, FAN Yuefei, DING Shouluan, WANG Chengwei. Efficacy and prognostic factors of gamma knife in treating 81 cases of brain metastases from lung cancer [J]. Journal of Shandong University (Health Sciences), 2022, 60(8): 44-49.
[2] ZUO Liping, JIANG Fengyang, ZHOU Binbin, FAN Jinlei, LIANG Yongfeng, DENG Zhanhao, YU Dexin. Value of preoperative multiphase MRI for predicting microvascular invasion and early recurrence of 169 hepatocellular carcinoma [J]. Journal of Shandong University (Health Sciences), 2022, 60(3): 89-95.
[3] Lixiao CHEN,Xinjiang YING,Xinwei CHEN,Fei WANG,Zhenfeng SUN,Pin DONG. Identification of proteins in hypopharyngeal squamous cell carcinoma by mass spectrometry and screening of prognostic target molecules [J]. Journal of Shandong University (Health Sciences), 2021, 59(9): 140-147.
[4] XIE Tonghui, CHEN Zhiqiang, CHANG Jianhua, ZHAO Danwen, XU Bowen, ZHI Xuting. Analysis of prognostic factors after radical resection of intrahepatic cholangiocarcinoma and establishment of a nomogram [J]. Journal of Shandong University (Health Sciences), 2021, 59(4): 93-99.
[5] LAN Hongtao, JIA Xu, TONG Zhoujie, ZHENG Man, HU Boang, ZHONG Ming, ZHANG Wei, WANG Zhihao. Readmission prediction of 152 non-selective adult patients with chronic heart failure [J]. Journal of Shandong University (Health Sciences), 2021, 59(4): 63-69.
[6] SONG Zhenzhen, SUN Xiaoling, LI Haiou, WANG Fang, ZHANG Ran, YU Dexin. Value of MRI radiomics of glioma and peritumoral edema in evaluating tumor recurrence [J]. Journal of Shandong University (Health Sciences), 2021, 59(11): 53-60.
[7] YOU Xueting, TIAN Xingsong. Analysis of clinicopathological characteristics of 3 514 cases of breast cancer over 9 years [J]. Journal of Shandong University (Health Sciences), 2021, 59(1): 49-54.
[8] WU Mengtao, WU Peng, YANG Yanfei, TANG Dianjun, MIAO Xiangling, LI Fandong. Application of CT venography in the diagnosis and treatment of recurrent lower extremity varicose veins [J]. Journal of Shandong University (Health Sciences), 2020, 1(9): 21-26.
[9] WANG Zhao. Advances in the clinical treatment of hemophagocytic lymphohistiocytosis [J]. Journal of Shandong University (Health Sciences), 2019, 57(7): 44-49.
[10] CHEN Linlin, YI Shaolei, WANG Weizong, LI Zhan, ZHANG Yong, ZHANG Yujiao,REN Manyi, XIE Xinxing, LIU Tongbao, HOU Yinglong. Risk factors of recurrent atrial fibrillation after radiofrequency catheter ablation [J]. Journal of Shandong University (Health Sciences), 2019, 57(3): 49-57.
[11] ZHOU Huimei, YANG Jiaxin, CAO Dongyan, SHEN Keng, XIANG Yang, WU Ming, PAN Lingya, HUANG Huifang, LANG Jinghe. Fertility-sparing radical trachelectomy for young women with early stage cervical cancer: surgical and obstetrical outcomes [J]. Journal of Shandong University (Health Sciences), 2018, 56(5): 18-22.
[12] YU Mei, YANG Jiaxin, CAO Dongyan, WANG Yao, SHEN Keng. Diagnosis and management in patients with recurrent stage I endometrial cancer after primary fertility-preserving treatment [J]. Journal of Shandong University (Health Sciences), 2018, 56(5): 23-29.
[13] WANG Jinhui, YANG Jiaxin, YUAN Zhen, CAO Dongyan, SHEN Keng, HUANG Huifang, WU Ming, PAN Lingya, GUO Lina. Preserve fertility in recurrent and uncontrolled malignant ovarian germ cell tumors [J]. Journal of Shandong University (Health Sciences), 2018, 56(5): 35-40.
[14] WANG Runmei, YANG Qiuhong, ZHANG Fang, MA Yuyan. Long-term prognosis of women preeclampsia and risks of incidence in their female offspring [J]. Journal of Shandong University (Health Sciences), 2017, 55(12): 31-35.
[15] YIN Xiaofang, GE Haibo. Epidemiological features of inpatients suffered from pulmonary tuberculosis with diabetes mellitus [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(1): 58-61.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd